The NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
Supported by Cambridge BRC, learn how a programme, developed by James Piercy, an 'expert of experience' who suffered a severe brain injury, ensures medical technology development is aligned with the unmet needs to brain injury survivors. @CUH_NHS @Cambridge_Uni @NIHRresearch
Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors.
Read more: https://orlo.uk/NfiZ3
@NIHR
Are you an academic developing medical technologies or professional services staff supporting them? @OTR_Cambridge & @RegMetrics are running a free online workshop on med devices regulations on Thurs 12 June 10-11.45am. To book: https://bit.ly/3SyrwWf @Cambridge_Uni @CUH_NHS
Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings
Quantitative 23Na magnetic resonance imaging in the abdomen at 3 T
Predicting patients with dementia most at risk of needing psychiatric inpatient or enhanced community care using routinely collected clinical data: retrospective multi-site cohort study.
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study
The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
Cortical gene expression architecture links healthy neurodevelopment to the imaging, transcriptomics and genetics of autism and schizophrenia
Childhood maltreatment influences adult brain structure through its effects on immune, metabolic, and psychosocial factors
Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease
Integration of polygenic and gut metagenomic risk prediction for common diseases
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study
Socioemotional and Psychological Outcomes of Hypoxic-Ischemic Encephalopathy: A Systematic Review
Antibiotic resistance determination using Enterococcus faecium whole-genome sequences: a diagnostic accuracy study using genotypic and phenotypic data
Prediction of spontaneous preterm birth using supervised machine learning on metabolomic data: A case–cohort study
Perseveration and shifting in obsessive–compulsive disorder as a function of uncertainty, punishment, and serotonergic medication.
Mitochondrial complex I activity in microglia sustains neuroinflammation
Genome-wide characterization ofcirculating metabolic biomarkers
Impact of penicillin allergy labels on surgical site infections in a large UK cohort of gastrointestinal surgery patients
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial
Estimating demand for potential disease-modifying therapies for Alzheimer’s disease in the UK
Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy